Champions Oncology reports record FY2021 revenue of $41M (+28% YoY); turns to operating profit of $338K

CHAMPIONS ONCOLOGY, INC.

FY2021 revenue $41.0M, up 28% from $32.1M; Q4 revenue $10.6M, up 21% from $8.8M.
Full-year operating income of $338K vs loss of $1.9M; Q4 operating loss narrowed to $456K from $2.0M.
Gross margin improved to 48% (FY2021) and 47% (Q4) vs 47% and 43% a year ago.
Cash position $4.7M with no debt; net cash used in ops $1.7M for the year.
Launched Lumin SaaS platform; developing AI/ML-driven target discovery using proprietary datasets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.